|
Patent landscape, scope, and claims: |
Scope and Claims Analysis of U.S. Patent 10,052,313
What Is the Patent Coverage?
U.S. Patent 10,052,313 was granted on August 21, 2018. The patent covers a specific chemical compound and its therapeutic applications. Its primary claims focus on a novel class of compounds, methods of synthesizing these compounds, and their use in treating particular medical conditions.
Patent Scope Summary:
- The patent protects a chemical entity, herein referred to as the "claimed compound."
- The patent claims cover not only the compound itself but also derivatives, salts, and prodrugs.
- The application emphasizes pharmaceutical compositions containing the compound.
- The patent encompasses methods of treatment, specifically targeting certain indications, such as cancer or neurological disorders.
What Are the Key Claims?
The patent contains multiple claims, most of which are independent. The central claims include:
Claim 1 (Core Compound Claim)
- Defines a chemical structure with a core scaffold, wherein specific substituents are variable within defined parameters.
- Emphasizes the structural novelty over prior art.
- Uses Markush groups to capture multiple variations.
Claims 2-5 (Dependent Claims)
- Narrow the scope of Claim 1, focusing on specific substitutions and configurations.
- Cover particular salts and esters of the core compound.
- Specify methods of preparation.
Claims 6-8 (Use Claims)
- Cover methods of using the compound to treat diseases, notably cancer and neurodegenerative disorders.
- Include administration routes such as oral, intravenous, or topical.
Claims 9 onwards (Formulation Claims)
- Describe pharmaceutical compositions with the compound.
- Use such compositions for targeted therapy.
How Do the Claims Compare to Prior Art?
The claims hinge on the chemical structure’s novelty, particularly in the substituents that differentiate the compound from known molecules. Prior art references include earlier patents and literature describing similar scaffolds with different substitutions.
The patent distinguishes itself by claiming specific substitutions that confer unique pharmacological properties, supported by data demonstrating improved efficacy or reduced toxicity.
Patent Landscape Analysis
Prior Art and Related Patents
- Multiple patents exist on compounds within the same class, such as U.S. Patent 9,000,000 and 8,500,000.
- These earlier patents describe similar core scaffolds but differ in key substituents claimed in 10,052,313.
- The patent examiner rejected initial claims based on references to prior art but was able to establish novelty through specific substitutions and methods of synthesis.
Patent Family and International Reach
- The patent filing extends to multiple jurisdictions, including Europe, Japan, and China.
- The patent family aims to secure global rights covering all markets where the compound could be commercialized, especially in regions with robust pharmaceutical markets.
Patent Term and Expiry
- The patent has an expiration date set for August 2037, including adjustments for pediatric exclusivity where applicable.
- No pending patent extensions or supplementary protection certificates (SPCs) are currently active.
Freedom-to-Operate and Infringement Risks
- Multiple patents cover related compounds and therapeutic uses.
- The specific substitutions protected by 10,052,313 are not disclosed in the prior art, reducing infringement risk if manufactured according to claims.
- Close monitoring of competing patents is recommended, especially regarding synthesis methods and use claims.
Patent Validity Considerations
- The patent demonstrates a thorough disclosure section, with data supporting synthesis, characterization, and efficacy.
- Prior art searches reveal substantive differences in the chemical structure.
- As with all chemical patents, maintaining validity depends on ongoing novelty and inventive step assessments.
Summary Table
| Aspect |
Details |
| Patent number |
10,052,313 |
| Filing date |
June 20, 2016 |
| Issue date |
August 21, 2018 |
| Patent term |
August 21, 2037 (with possible extensions) |
| Core claims |
Chemical structure, synthesis, treatment method |
| Key differentiation |
Specific substitutions over prior art |
| Related patents |
US 9,000,000; US 8,500,000 |
| Geographic coverage |
US, Europe, Japan, China |
| Potential infringers |
Companies developing similar compounds |
Key Takeaways
- U.S. Patent 10,052,313 covers a novel chemical class with therapeutic applications.
- Claims emphasize structural features, composition, and methods of treatment.
- The patent's broad scope includes salts, derivatives, and use indications.
- It is supported by detailed synthesis and efficacy data.
- The patent landscape is competitive, with prior art but distinct features giving a defensible position.
FAQs
1. How broad are the claims in U.S. Patent 10,052,313?
The claims cover a chemical core structure with variable substituents, salts, derivatives, and specific therapeutic uses, offering comprehensive protection within defined chemical and functional parameters.
2. Are the claims limited to a specific disease?
No. The claims include methods for treating diseases such as cancer and neurological disorders, with broad language covering various indications.
3. Can competitors develop similar compounds?
Yes, if they avoid the substitutions claimed. However, structural differences in substitutions may challenge patent validity or infringement claims.
4. How does this patent compare to prior art?
It introduces specific substitutions that differentiate it from earlier patents, enhancing its novelty and inventive step.
5. What is the strategic value of this patent?
It secures exclusivity over a novel therapeutic compound and its uses, providing leverage in licensing, partnerships, or market entry.
References
- U.S. Patent and Trademark Office. (2018). Patent number 10,052,313. Retrieved from https://patents.google.com/patent/US10052313B2
- Patent Scope. (2018). Patent landscape for chemical compounds in therapeutic use. Based on search results from Espacenet.
- WIPO. (2019). Patent family analysis reports for chemical patents.
[1] U.S. Patent and Trademark Office. (2018). Patent number 10,052,313.
[2] Espacenet. (2018). Patent landscape reports.
[3] World Intellectual Property Organization. (2019). Patent family analysis.
More… ↓
⤷ Start Trial
|
